Alliance A021703- Randomized Double-Blind Phase III Trial Of Vitamin D3 Supplementation In Patients With Previously Untreated Metastatic Colorectal Cancer
Posted Date: Feb 27, 2020
- Investigator: Tahir Latif
- Specialties: Cancer, Colorectal Cancer, Oncology
- Type of Study: Drug
The primary goal of this study is To compare the progression-free survival (PFS) of patients receiving high-dose vitamin D3 in ombination with standard chemotherapy (FOLFOX or FOLFIRI) and bevacizumab versus hose receiving standard-dose vitamin D3 in combination with standard chemotherapy and bevacizumab
Criteria:
To Be Eligible: Must Have Advanced/Metastatic Colorectal Adenocarcinoma, Measureable Disease, Ecog 0-1, No Prior Treatment For Study Cancer, No Resectable Disease, No History Of Chf, Hypercalcemia, Or Other Active Uncontrolled Concurrent Illness Or Infection
Keywords:
Colorectal Cancer, Colon, Oncology
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com